Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clotting Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01006733
What this trial is testing

Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT

Who this might be right for
Thromboembolism
Washington University School of Medicine 1,598
Not applicableStudy completedNCT05486338
What this trial is testing

Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy

Who this might be right for
ObesityAdiposity
Erbe Elektromedizin GmbH 15
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208
Post-approval studies (Phase 4)UnknownNCT04102033
What this trial is testing

Eltrombopag in Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Assiut University 20
Large-scale testing (Phase 3)Study completedNCT04158648
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Who this might be right for
Mild Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHemophilia A
Hoffmann-La Roche 73
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT04434001
What this trial is testing

ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery

Who this might be right for
BleedingCardiac DefectSurgery--Complications+4 more
IRCCS Policlinico S. Donato 40
Not applicableUnknownNCT02197611
What this trial is testing

Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.

Who this might be right for
Haemophilia
Universidad de Murcia 100
Testing effectiveness (Phase 2)UnknownNCT05441553
What this trial is testing

Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients

Who this might be right for
Hemophilia B
Shanghai Vitalgen BioPharma Co., Ltd. 26
Not applicableStudy completedNCT03157154
What this trial is testing

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

Who this might be right for
Hemophilia
Nantes University Hospital 259
Not applicableUnknownNCT04508439
What this trial is testing

Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection

Who this might be right for
Covid19PneumoniaCoagulation Disorder+1 more
Hospital Regional de Alta especialidad de Ixtapaluca 130
Testing effectiveness (Phase 2)Study completedNCT03842657
What this trial is testing

Regional Anticoagulation of Dialysis Circuits With a Calcium-free Citrate-containing Dialysate

Who this might be right for
Hemodialysis ComplicationBleeding
University Hospital, Toulouse 97
Large-scale testing (Phase 3)WithdrawnNCT02137681
What this trial is testing

A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

Who this might be right for
Immune Thrombocytopenia
Shandong University
Early research (Phase 1)Study completedNCT00442871
What this trial is testing

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 29
Testing effectiveness (Phase 2)Study completedNCT04743011
What this trial is testing

Enriched Heparin Anti COVID-19 Trial

Who this might be right for
Covid19
UPECLIN HC FM Botucatu Unesp 27
Large-scale testing (Phase 3)Study completedNCT05566990
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
SK Plasma Co., Ltd. 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT07733037
What this trial is testing

Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 42
Testing effectiveness (Phase 2)Looking for participantsNCT04644211
What this trial is testing

Ruxolitinib in Thrombocythemia and Polycythemia Vera

Who this might be right for
Essential ThrombocythemiaPolycythemia Vera
Massachusetts General Hospital 60
Early research (Phase 1)Study completedNCT03603132
What this trial is testing

Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 15
Not applicableUnknownNCT05523128
What this trial is testing

The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.

Who this might be right for
Hemophilia A
Institute of Hematology & Blood Diseases Hospital, China 6
Next Page